IW Capital Leads £10.35m Investment Into Strolll

IW Capital has led a £10.35m investment round into Strolll, a fast-growing digital therapeutics company using augmented reality (AR) to transform neurorehabilitation.

Strolll’s software turns physiotherapy into immersive, game-based exercises for people living with neurological conditions such as Parkinson’s disease and multiple sclerosis.

The company has already secured major clinical partnerships, including a £2.4m NIHR-backed trial with leading NHS trusts and a $3m collaboration with Cleveland Clinic in the US.

With this new investment, Strolll will accelerate sales and marketing, broaden its product range, and expand into new therapeutic areas. In a market where demand for innovative neurorehabilitation is only increasing, the company is exceptionally well positioned to scale globally.

Commenting on the investment, IW Capital’s Investment Director, Isobel Egemole, says, “IW Capital are thrilled to announce our investment into Strolll. Strolll are transforming the physiotherapy and neurorehabilitation markets and have already helped a significant number of people with debilitating neurological disorders to live better lives. The potential impact of their software is huge and we’re proud to be backing this cutting-edge business as it addresses key healthcare needs.”

Jorgen Ellis, CEO of Strolll said, “Strolll are at an exciting inflection point in our journey and we are delighted to be partnering with IW Capital, as well as other investment partners, as we look to accelerate the growth of our business. We are positioned at the forefront of the neurorehabilitation market and we’re passionate about helping to improve the care that patients with neurological disorders receive. We thank investors for believing in our vision of healthcare and we look forward to building on our achievements to date.”

You can read coverage of the news on sky news here.